Corrigendum re “A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)” [Eur Urol Focus 2022;8:173–81] (European Urology Focus (2022) 8(1) (173–181), (S2405456921000158), (10.1016/j.euf.2021.01.014))
Zhenjie Wu, Qi Chen, Hooman Djaladat, Andrea Minervini, Robert G. Uzzo, Chandru Sundaram, Koon H. Rha, Mark L. Gonzalgo, Reza Mehrazin, Elio Mazzone, Jamil Marcus, Alyssa Danno, James Porter, Aeen Asghar, Fady Ghali, Georgi Guruli, Antoin Douglawi, Giovanni Cacciamani, Alireza Ghoreifi, Giuseppe SimoneVitaly Margulis, Matteo Ferro, Riccardo Tellini, Andrea Mari, Abhishek Srivastava, James Steward, Ali Al-Qathani, Ahmad Al-Mujalhem, Amit Satish Bhattu, Alexander Mottrie, Firas Abdollah, Daniel D. Eun, Ithaar Derweesh, Alessandro Veccia, Riccardo Autorino, Linhui Wang
Research output: Contribution to journal › Comment/debate › peer-review
Fingerprint
Dive into the research topics of 'Corrigendum re “A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)” [Eur Urol Focus 2022;8:173–81] (European Urology Focus (2022) 8(1) (173–181), (S2405456921000158), (10.1016/j.euf.2021.01.014))'. Together they form a unique fingerprint.